Allergy is a hyper-sensitivity to a specific substance which, if inhaled, ingested, touched or injected, causes characteristic symptoms.
ALL INMUNOTEK NEWS
Allergoid-mannan conjugated vaccines in the Allergo Journal International. A review of these novel vaccines that represent a next generation of allergen immunot... More info
The US Patent Office has granted to INMUNOTEK the patent US9901633B2. This refers to new glycoconjugates performed with non-oxidized mannan derived from S. cere... More info
Inc. magazine revealed the 2018 Inc. 5000 list of fastest-growing private companies in Europe. With an accumulated growth of more than 80%, INMUNOTEK has made ... More info
INNOVATING AND SHARING IDEAS Since 1992
From the outset, in 1992, our goal has been to offer innovative andcompetitive products of the highest quality, useful for professionals and safe and effective for the treatment of patients. To this end we have put together a highly professional and motivated team; we have outstanding facilities and a broad product porfolio.
Inmunotek complies with GMPs, and their products are approved by the Spanish Drug Agency and several international regulatory agencies.